FindTrial
Sign In

Application of botulinum toxin A in the treatment of strabismus

Application of botulinum toxin A in the treatment of strabismus

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082138
Enrollment
Unknown
Registered
2024-03-21
Start date
2022-08-02
Completion date
Unknown
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

strabismus

Interventions

BTXA group :injection of botulinum toxin A
surgery group:surgery

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) diadnosed with strabismus. (2) Best corrected visual acuity in both eyes is not less than 20/20. (3) The compliance was good and could be followed up for 1 year or more.

Exclusion criteria

Exclusion criteria: 1) A history of eye disease, including strabismus, amblyopia, or other related eye disease. (2) Previous history of eye surgery. (3) A history of systemic disease related to diabetes, hypertension, and myasthenia gravis. (4)Neuroimaging examination found intracranial lesions.

Design outcomes

Primary

MeasureTime frame
Treatment success rate;Prism diopte;—

Secondary

MeasureTime frame
Synoptophore;Stereoacuity;Visual quality score;—

Countries

China

Contacts

Public ContactLongqian Liu

West China Hospital, Sichuan University

b.q15651@hotmail.com+86 189 8060 1759

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026